Antifungal Resistant Gastrointestinal Basidiobolomycosis Without Eosinophilia: A Case Report

AuthorMajid Golestani Eraghien
AuthorMihan Pourabdollah Toutkabonien
AuthorBehrooz Farzaneganen
AuthorMajid Marjanien
AuthorSeyed Mohammad Reza Hashemianen
AuthorPayam Tabarsien
OrcidPayam Tabarsi [0000-0002-8932-5420]en
Issued Date2017-10-31en
AbstractIntroduction: Gastrointestinal basidiobolomycosis (GIB) is an emerging fatal infection in healthy individuals with limited known signs and symptoms. Case Presentation: A 42 years old labor man was admitted to the intensive care unit (ICU) of Masih Daneshvari hospital, Tehran, Iran, with chronic abdominal pain, a fever, and suspicion to post-operative abdominal infection. The patient had undergone an appendectomy as well as a colorectal surgery and a colostomy had been placed. The histopathological study of the colon was identical for gastrointestinal basidiobolomycosis. There was no eosinophilia in the peripheral blood sample. Patients’ treatment using itraconazole, voriconazole, and amphotericin B was not successful and unfortunately, he died because of septic shock. Conclusions: GIB is an emerging and fatal fungal infection with non-specific presentation such as abdominal pain, mass, and fever in healthy individuals. Persistent leukocytosis with or without eosinophilia, resistant fever, and other signs and symptoms after surgical resection, patients job and residents are important clue and insert the basidiobolomycosis in list of differential diagnoses is most important factor to early diagnosis and treatment.en
DOIhttps://doi.org/10.5812/archcid.66110en
KeywordBasidiobolomycosisen
KeywordFungal Infectionen
KeywordGastrointestinal Infectionen
KeywordImmunocompetenten
KeywordZygomycosisen
PublisherBrieflandsen
TitleAntifungal Resistant Gastrointestinal Basidiobolomycosis Without Eosinophilia: A Case Reporten
TypeCase Reporten

Files